Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Approves LimaCorporate's PRIMA Shoulder Platform - Orthopedic Design & Technology

What are you searching for?

Sign in

FDA Approves LimaCorporate’s PRIMA Shoulder Platform

First approval includes 3D-printed Short Stem and TT Glenoid components.

Author Image

By: Sam Brusco

Associate Editor

LimaCorporate has earned U.S. Food and Drug Administration (FDA) approval for its PRIMA shoulder platform.
 
The PRIMA shoulder’s glenoid baseplate and humeral stem are fully 3D-printed, a first for the company. The implant uses the firm’s Trabecular Titanium (TT) technology to encourage strong primary fixation and secondary bone growth.
 
A bone-preserving, fully convertible design facilitates simple exchange from anatomic to reverse configuration. Surgeons can move between baseplate designs to address different pathologies in a range of complexities.
 
“[This] FDA approval for PRIMA TT Glenoid represents an exciting opportunity to accelerate our market growth in key regions,” newly minted LimaCorporate CEO Massimo Calafiore told the press. “The new PRIMA shoulder platform will support our surgeons to bring the emotion of motion to even more patients!”

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Add Orthopedic Design & Technology as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters

Topics